drugset

drugset / Trial / NCT00215137

Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder

NCT00215137 ↗

Phase 2 Completed 14 enrolled Duke University Forest Laboratories · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will determine the safety and effectiveness of escitalopram (Lexapro)in treating obsessive-compulsive disorder (OCD) symptoms.

Timeline

Start: 2004-10
Primary completion: 2009-01
Completion: 2009-03

Publications

Results C. Joseph Wang, M.D., Ph.D.; Jonathan R. Davidson, M.D.; Kathryn M. Connor, M.D.;Weihui Li1, M.D.,Ph.D. and Wei Zhang, M.D., Ph.D. Unpublished Manuscript

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Escitalopram	Small molecule	20 mg	—

Indications